Pharma Marketing News Vol. 14, No. 7: December 2015
Welcome to Vol. 14, Issue No. 7 (DECEMBER 2015) of Pharma Marketing News. DTC Ban Revisited, Digital Disruption, Best of 2015, are the themes of this issue.
Anti-DTC Resurgence: Physicians and Politicians Call for Bans, Moratoriums, & End to Tax Breaks
With the renewed focus on the high cost of drugs comes a new wave of attacks on Direct-to-Consumer Advertising (DTCA) of prescription drugs. But is there a causal link between DTC advertising and Rx drug prices and/or total spending? This article explores this issue.
How to Achieve Digital Pharma Marketing Results: Dealing with Disruption
This article focuses on digital disruption, which is the focus of a chapter in the book RESULTS: The Future of Pharmaceutical and Healthcare Marketing written by by R.J. Lewis (aka RJ) et al.
Pharma Marketing: The Year 2015 in Images
Pharmaguy's Favorite Images with Commentary from Pharma Marketing Blog, Pharma Marketing News, and Scoops
Pharma Marketing News Vol. 14, No. 6: September 2015
Welcome to Vol. 14, Issue No. 6 (SEPTEMBER 2015) of Pharma Marketing News. Medical conference hashtags, celebrities + social media, and Patient Power are the themes of this issue.
Pharma’s Use of Medical Conference Twitter Hashtags: Is It “Backchannel” Promotion That Needs to...
This article discusses the pros and cons of safeguards proposed a group of academic physicians (the #MICEproject) to limit pharmaceutical 'detailing' and to 'bring the medical community closer to establishing guidelines for third party activities in Twitter back-channels.'
Celebrities + Social Media: Balancing Benefits and Risks
This article focuses on the risks and benefits of using celebrities and social media to promote pharma brands and proposes that it may be time for the pharma industry to disclose the details of payments made to celebrities as they now are required to do for physician payments.
The Power of Patient Input: How FDA Learned to Love & Approve Addyi
This article presents a case study of how patient input has the power to change the course of drug approval. The case is Sprout's ground-breaking patient campaign that played a major role in getting Addyi, a female sexual dysfunction drug, approved by the FDA.
Wearables, Ingestibles, Implantables: The Inescapable Future of Healthcare
This article discusses the intrusiveness of wearables et al and other issues of these technologies as they relate to healthcare outcomes and communications arena and whether pharma marketers should get on the bandwagon.
Pharma Marketing News Vol. 14, No. 5: June 2015
Welcome to Vol. 14, Issue No. 5 (JUNE 2015) of Pharma Marketing News. Creativity and new technology in the service of patient communications and healthcare outcomes are the themes of this issue.